coronavirus treatment

The drug combination from Regeneron Pharmaceuticals cut patient deaths from 30% to 24% among those who hadn’t already developed an immune response against COVID-19.

Philanthropies are funding studies of cheap, existing meds like fluvoxamine as treatments. But early hype about hydroxychloroquine and other drugs leaves researchers leery of hasty conclusions.

Regeneron says tests in more than 4,000 recently diagnosed patients found its two-antibody combo drug cut the risk of hospitalization or death by 70%.

Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits.

Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.

Speaking in a video released Wednesday morning, Gov. Ron DeSantis announced plans for the distribution of possible COVID-19 vaccines.

The drug is a combo of two antibodies to enhance the chances it will prove effective. It's an experimental medicine that President Trump was given when he was sickened last month.

President Donald Trump is among those who have been treated with remdesivir, and FDA-approval could widen access to more patients.

A vaccine will only work if a lot of people can get immunized. State health officials are working furiously to design outreach and distribution plans, with little clarity from the federal government.

Federal, Florida and local law enforcement officials who have recovered from COVID-19 are partnering with OneBlood to raise awareness about plasma…